A phase II study of axitinib in advanced carcinoid tumors: Preliminary results

Authors :: Chloe E. Atreya
Thomas Weber
Tiffany Campos
Jonathan R. Strosberg
Mauro Cives
Emily K. Bergsland
Domenico Coppola
Alan P. Venook
Tiffany Valone
McKinley Nickerson
Robin Kate Kelley
Source :: Journal of Clinical Oncology. 33:4100-4100
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: 4100 Background: Neuroendocrine tumors (NETs) are highly vascular neoplasms overexpressing VEGF as well as VEGFR. Axitinib is an inhibitor of receptor tyrosine kinases with picomolar potency agains...

Tools